• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与ALFQ佐剂结合的保守流感血凝素、神经氨酸酶和基质肽可诱导广泛中和抗体。

Conserved Influenza Hemagglutinin, Neuraminidase and Matrix Peptides Adjuvanted with ALFQ Induce Broadly Neutralizing Antibodies.

作者信息

Sei Clara J, Rao Mangala, Schuman Richard F, Daum Luke T, Matyas Gary R, Rikhi Nimisha, Muema Kevin, Anderson Alexander, Jobe Ousman, Kroscher Kellie A, Alving Carl R, Fischer Gerald W

机构信息

Longhorn Vaccines and Diagnostics, Gaithersburg, MD 20878, USA.

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.

出版信息

Vaccines (Basel). 2021 Jun 25;9(7):698. doi: 10.3390/vaccines9070698.

DOI:10.3390/vaccines9070698
PMID:34202178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8310080/
Abstract

A universal influenza candidate vaccine that targets multiple conserved influenza virus epitopes from hemagglutinin (HA), neuraminidase (NA) and matrix (M2e) proteins was combined with the potent Army liposomal adjuvant (ALFQ) to promote induction of broad immunity to seasonal and pandemic influenza strains. The unconjugated and CRM-conjugated composite peptides formulated with ALFQ were highly immunogenic and induced both humoral and cellular immune responses in mice. Broadly reactive serum antibodies were induced across various IgG isotypes. Mice immunized with the unconjugated composite peptide developed antibody responses earlier than mice immunized with conjugated peptides, and the IgG antibodies were broadly reactive and neutralizing across Groups 1 and 2 influenza viruses. Multi-epitope unconjugated influenza composite peptides formulated with ALFQ provide a novel strategy for the development of a universal influenza vaccine. These synthetic peptide vaccines avoid the pitfalls of egg-produced influenza vaccines and production can be scaled up rapidly and economically.

摘要

一种针对血凝素(HA)、神经氨酸酶(NA)和基质(M2e)蛋白中多个保守流感病毒表位的通用流感候选疫苗,与强效的陆军脂质体佐剂(ALFQ)联合使用,以促进对季节性和大流行性流感毒株产生广泛免疫。用ALFQ配制的未缀合和CRM缀合复合肽具有高度免疫原性,并在小鼠中诱导了体液免疫和细胞免疫反应。在各种IgG同种型中均诱导出广泛反应性血清抗体。用未缀合复合肽免疫的小鼠比用缀合肽免疫的小鼠更早产生抗体反应,并且IgG抗体对第1组和第2组流感病毒具有广泛反应性和中和作用。用ALFQ配制的多表位未缀合流感复合肽为通用流感疫苗的开发提供了一种新策略。这些合成肽疫苗避免了鸡蛋生产的流感疫苗的缺陷,并且生产可以快速且经济地扩大规模。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/071e4a3a0c5d/vaccines-09-00698-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/801c7821504b/vaccines-09-00698-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/371328bbff7f/vaccines-09-00698-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/994906d43c66/vaccines-09-00698-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/bad78c445f06/vaccines-09-00698-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/7e2efd2540ae/vaccines-09-00698-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/1a242eb7e57b/vaccines-09-00698-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/071e4a3a0c5d/vaccines-09-00698-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/801c7821504b/vaccines-09-00698-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/371328bbff7f/vaccines-09-00698-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/994906d43c66/vaccines-09-00698-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/bad78c445f06/vaccines-09-00698-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/7e2efd2540ae/vaccines-09-00698-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/1a242eb7e57b/vaccines-09-00698-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0324/8310080/071e4a3a0c5d/vaccines-09-00698-g007.jpg

相似文献

1
Conserved Influenza Hemagglutinin, Neuraminidase and Matrix Peptides Adjuvanted with ALFQ Induce Broadly Neutralizing Antibodies.与ALFQ佐剂结合的保守流感血凝素、神经氨酸酶和基质肽可诱导广泛中和抗体。
Vaccines (Basel). 2021 Jun 25;9(7):698. doi: 10.3390/vaccines9070698.
2
Unconjugated Multi-Epitope Peptides Adjuvanted with ALFQ Induce Durable and Broadly Reactive Antibodies to Human and Avian Influenza Viruses.与ALFQ佐剂结合的未偶联多表位肽可诱导产生针对人类和禽流感病毒的持久且广泛反应性的抗体。
Vaccines (Basel). 2023 Sep 8;11(9):1468. doi: 10.3390/vaccines11091468.
3
Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.合成的Toll样受体4(TLR4)和TLR7配体作为流感病毒疫苗佐剂可诱导快速、持久且具有广泛保护性的反应。
J Virol. 2015 Mar;89(6):3221-35. doi: 10.1128/JVI.03337-14. Epub 2015 Jan 7.
4
Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.含单磷酰脂质A(有无QS21)的脂质体佐剂配方诱导的对HIV-1包膜蛋白的差异性免疫反应
Vaccine. 2015 Oct 13;33(42):5578-5587. doi: 10.1016/j.vaccine.2015.09.001. Epub 2015 Sep 13.
5
Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.补体 C3 在诱导针对流感病毒株特异性血凝素的体液和细胞免疫应答以及交叉保护 M2 细胞外域的疫苗接种中发挥关键作用。
J Virol. 2018 Sep 26;92(20). doi: 10.1128/JVI.00969-18. Print 2018 Oct 15.
6
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.新型 H3 特异性广谱中和单克隆抗体的鉴定 该抗体靶向血凝素球状头部,来源于一位具有广泛血清学反应性的流感病毒免疫供者
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01035-19.
7
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.神经氨酸酶抑制抗体滴度与对同一神经氨酸酶亚型的异源流感病毒株的保护作用相关。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.01006-18. Print 2018 Sep 1.
8
Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.H5N1 流感病毒血凝素的构象稳定性影响对广谱中和茎部抗体的敏感性。
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00247-18. Print 2018 Jun 15.
9
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.接种表达神经氨酸酶的重组副流感病毒5可抵御同源和异源流感病毒攻击。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01579-17. Print 2017 Dec 1.
10
Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies.流感 A 病毒多表位诱导中和抗体的生物信息学设计与实验验证。
Arch Virol. 2020 Apr;165(4):891-911. doi: 10.1007/s00705-020-04537-2. Epub 2020 Feb 14.

引用本文的文献

1
Adjuvant-free, self-assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses.不含佐剂、自组装的铁蛋白纳米颗粒疫苗与携带M1和PADRE表位的流感病毒血凝素蛋白偶联,可引发交叉保护性免疫反应。
Front Immunol. 2025 Jan 31;16:1519866. doi: 10.3389/fimmu.2025.1519866. eCollection 2025.
2
Development of semisynthetic saponin immunostimulants.半合成皂苷免疫刺激剂的研发
Med Chem Res. 2024;33(8):1292-1306. doi: 10.1007/s00044-024-03227-x. Epub 2024 May 18.
3
Unconjugated Multi-Epitope Peptides Adjuvanted with ALFQ Induce Durable and Broadly Reactive Antibodies to Human and Avian Influenza Viruses.

本文引用的文献

1
Vaccines for Influenza.流感疫苗
Vaccines (Basel). 2021 Jan 14;9(1):47. doi: 10.3390/vaccines9010047.
2
The Next Generation of Influenza Vaccines: Towards a Universal Solution.下一代流感疫苗:迈向通用解决方案
Vaccines (Basel). 2021 Jan 7;9(1):26. doi: 10.3390/vaccines9010026.
3
Tracking progress in universal influenza vaccine development.追踪通用流感疫苗研发进展。
与ALFQ佐剂结合的未偶联多表位肽可诱导产生针对人类和禽流感病毒的持久且广泛反应性的抗体。
Vaccines (Basel). 2023 Sep 8;11(9):1468. doi: 10.3390/vaccines11091468.
4
Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21.佐剂系统 01 和 Army 脂质体制剂与 QS21 的化学成分、物理和功能特性的异同。
Front Immunol. 2023 Jan 25;14:1102524. doi: 10.3389/fimmu.2023.1102524. eCollection 2023.
5
Monophosphoryl lipid A-adjuvanted nucleoprotein-neuraminidase nanoparticles improve immune protection against divergent influenza viruses.单磷酰脂质 A 佐剂化核蛋白-神经氨酸酶纳米颗粒增强对不同流感病毒的免疫保护作用。
Nanomedicine. 2023 Jan;47:102614. doi: 10.1016/j.nano.2022.102614. Epub 2022 Oct 17.
6
Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development.基于噬菌体 T4 的疫苗平台在下一代流感疫苗研发中的应用。
Front Immunol. 2021 Oct 12;12:745625. doi: 10.3389/fimmu.2021.745625. eCollection 2021.
Curr Opin Virol. 2020 Feb;40:28-36. doi: 10.1016/j.coviro.2020.02.003. Epub 2020 Apr 9.
4
Army Liposome Formulation (ALF) family of vaccine adjuvants.陆军脂质体配方(ALF)疫苗佐剂家族。
Expert Rev Vaccines. 2020 Mar;19(3):279-292. doi: 10.1080/14760584.2020.1745636. Epub 2020 Mar 31.
5
Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.神经氨酸酶,被遗忘的表面抗原,作为流感疫苗靶点出现,以实现更广泛的保护。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S75-S80. doi: 10.1093/infdis/jiz017.
6
Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination.接种三价流感灭活疫苗后,针对同源和异源 H1 和 H3 流感病毒株的中和抗体反应随年龄和前一年的疫苗接种而变化。
Clin Infect Dis. 2019 May 30;68(12):2067-2078. doi: 10.1093/cid/ciy818.
7
The influenza virus hemagglutinin head evolves faster than the stalk domain.流感病毒血凝素头部比茎部进化得更快。
Sci Rep. 2018 Jul 11;8(1):10432. doi: 10.1038/s41598-018-28706-1.
8
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.人类流感感染诱导广泛交叉反应和保护性神经氨酸酶反应性抗体。
Cell. 2018 Apr 5;173(2):417-429.e10. doi: 10.1016/j.cell.2018.03.030.
9
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant.海洛因 - 人类免疫缺陷病毒1型(H2)疫苗:以脂质体脂A为佐剂,用海洛因半抗原偶联物和人类免疫缺陷病毒1型包膜V2肽诱导双重免疫效应。
NPJ Vaccines. 2017 May 2;2:13. doi: 10.1038/s41541-017-0013-9. eCollection 2017.
10
A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse.一种稳定的海洛因类似物,可用作疫苗半抗原,诱导抗体,阻断海洛因及其代谢物在啮齿动物中的作用,并与相关滥用药物发生免疫交叉反应。
J Med Chem. 2018 Jan 11;61(1):329-343. doi: 10.1021/acs.jmedchem.7b01427. Epub 2017 Dec 29.